Akums Drugs and Pharmaceuticals ltd

Established in 2004, Akums Drugs and Pharmaceuticals Limited is a pharmaceutical contract development and manufacturing organization (CDMO) offering a comprehensive range of pharmaceutical products and services in India and overseas.

The company primarily provides end-to-end solutions for product development and manufacturing as well as research and development (R&D) of formulations, preparation and submission of regulatory dossiers in the Indian and global markets and other testing services. The company is also engaged in the manufacture and sale of branded drugs and active pharmaceutical ingredients (APIs).

As a CDMO, the company manufactures a wide range of dosage forms including tablets, capsules, liquid medicines, vials, ampoules, blow-filled closures, topical preparations, eye drops, dry powder injections and gummy bears, to name a few.

The company has produced a total of 4,025 commercialized formulations in over 60 dosage forms. In the financial year 2023, the company manufactured formulations for 26 of The company has produced a total of 4,025 commercialized formulations in over 60 dosage forms. In the financial year 2023, the company manufactured formulations for 26 of the top 30 pharmaceutical companies in India in terms of revenue. For its CDMO business, the company operates 10 manufacturing units with a cumulative production capacity of 49.21 billion units annually (as of September 30, 2023).

The company plans to expand its production capacity with two additional production units for its CDMO business to be commissioned in FY 2025. Some of its production facilities have been accredited by various global regulatory bodies such as the European Good Manufacturing Practice (EU-GMP), the World Health Organization Good Manufacturing Practice (WHO-GMP) and the United States National Sanitation Foundation (US NSF).

As of September 30, 2023, Akums Drugs and Pharmaceuticals had a total of 16,463 employees, including 7,211 full-time employees and 9,252 contract employees.

 

Akums Drugs and Pharmaceuticals Limited Financial Information (Restated Consolidated)

Akums Drugs and Pharmaceuticals Limited’s revenue increased by 13.81% and profit after tax (PAT) dropped by -99.19% between the financial year ending with March 31, 2024 and March 31, 2023.

Period Ended31 Mar 202431 Mar 202331 Mar 2022
Assets3,516.373,266.533,069.05
Revenue4,212.213,700.933,694.52
Profit After Tax0.7997.82-250.87
Net Worth709.50717.19621.98
Reserves and Surplus861.01868.70787.79
Total Borrowing491.56536.97357.95
Amount in ₹ Crore

Objects of the Issue (Akums Drugs and Pharmaceuticals IPO Objectives)

The Company proposes to utilize the Net Proceeds towards the funding of the following objects:

  1. Repayment/ prepayment of indebtedness of the company and its Subsidiaries;
  2. Funding incremental working capital requirements of the company;
  3. Pursuing inorganic growth initiatives through acquisitions; and
  4. General corporate purposes.

Akums Drugs and Pharmaceuticals IPO Timeline (Tentative Schedule)

Akums Drugs and Pharmaceuticals IPO opens on July 30, 2024, and closes on August 1, 2024.

IPO Open DateTuesday, July 30, 2024
IPO Close DateThursday, August 1, 2024
Basis of AllotmentFriday, August 2, 2024
Initiation of RefundsMonday, August 5, 2024
Credit of Shares to DematMonday, August 5, 2024
Listing DateTuesday, August 6, 2024
Cut-off time for UPI mandate confirmation5 PM on August 1, 2024

SHARIAH SCREENING for - Akums Drugs and Pharmaceuticals Limited IPO

Looking to invest ethically or according to Islamic principles? Expert Ethical brokers can help. Whether you need an ethical investment broker, a halal stock broker in India, or a Shariah-compliant broker, there are specialists available. Discover how to align your investments with your values and start your journey towards ethical wealth creation today through Ethical IAP or Ethical PMS.

Visit Prosperia.in to learn more about Ethical Investment Opportunities and start your journey towards ethical wealth creation today.

BUSINESS SCREEN

FINANCIAL RATIOS

As per our analysis and Based on the information we have, this is the output.
Allah knows best.
If you find this result mistaken or questionable, let us know via email at info (@) halalstock.in

Spread the Knowledge - Share the Latest IPO Updates and Shariah Compliant IPO's.

Latest Current & Upcoming IPOs in BSE & NSE - Including Shariah Compliant.

The IPO dashboard offers insights on the Latest Current & Upcoming IPOs in BSE & NSE. It also evaluates IPOs for Shariah compliance, ensuring alignment with Islamic principles for ethical investment choices.

IPO

Infonative Solutions Limited IPO Detail

Last Updated on March 27, 2025 Infonative Solutions Limited IPO Incorporated in 2014, Infonative Solutions Ltd specializes in custom learning development solutions for corporate and educational sectors. The company focuses

Read More »
IPO

Spinaroo Commercial Limited IPO Detail

Last Updated on March 27, 2025 Spinaroo Commercial Limited IPO Incorporated in August 17, 2012, Spinaroo Commercial Limited is engaged in the manufacturing of aluminum foil containers, aluminum home foil,

Read More »

Dear Halal Stock Users,

If you believe our website is a valuable resource,
we invite you to support us.
Your contribution ensures free access for all
and fuels future development.

You can contribute as little as
100, 200, 500 & so…
every bit counts.

Thank you for your support!